ABSTRACT Purpose To evaluate the influence of bioactive glass and photobiomodulation therapy (PBMT) in calvarial bone repair process in rats submitted to zoledronic acid therapy. Methods Twenty-four rats were selected and treated with the dose of 0.035 mg/kg of zoledronic acid every two weeks, totalizing eight weeks, to induce osteonecrosis. After the drug therapy, surgical procedure was performed to create 5-mm diameter parietal bone defects in the calvarial region. The rats were then randomly assigned to groups according to the following treatments: AZC: control group, treated with blood clot; AZBIO: bone defect filled with bioactive glass; AZL: treated with blood clot and submitted to PBMT; and AZBIOL: treated with bioactive glass S53P4 and submitted to PBMT. Tissue samples were collected and submitted to histomorphometric analysis after 14 and 28 days. Results At 14 days, bone neoformation in the AZBIO (52.15 ± 9.77) and AZBIOL (49.77 ± 13.58) groups presented higher values (p ≤ 0.001) compared to the AZC (23.35 ± 10.15) and AZL groups (23.32 ± 8.75). At 28 days, AZBIO (80.24 ± 5.41)still presented significant higher bone recovery values when compared to AZC (59.59 ± 16.92)and AZL (45.25 ± 5.41) groups (p = 0.048). In the 28-day period, the AZBIOL group didn’t show statistically significant difference with the other groups (71.79 ± 29.38). Conclusions The bioactive glass is an effective protocol to stimulate bone neoformation in critical defects surgically created in rats with drug induced osteonecrosis, in the studied periods of 14 and 28 days.

ABSTRACT: Objective: To analyze the level of survival and the main complications presented by total edentulous patients after the All-on-Four® treatment, through a retrospective analysis. Methods: The medical records of 32 rehabilitated patients, between 2010 to 2018 were selected, presenting a total of 128 implants with subsequent fixed prostheses. The following variables were analyzed: gender, age, patient’s systemic condition, time of implant installation, number of implants, and surgical and prosthetic complications. Results: The procedures were performed over on average 5.9 years ago and were more prevalent in female patients(59.6%). Out of the 32 patients selected 75% presented some systemic alteration, with hypertension being the most frequent disease. Regarding the implant placement, the rehabilitation in the mandible was more prevalent(62.5%), while in the maxilla(31.2%), and in the bimaxillary region(6.25%). As for the complications, out of 128 implants installed, 13 presented loss of osseointegration, leading to a survival rate of 90.44% (94.3% mandible and 83.3% maxilla). Furthermore, 15 surgical and 20 prosthetic complications were diagnosed. Among the surgical complications, the most frequent were loss(5-33%) and bone fracture(3-20%), while the most frequent prosthetic complications included loosening and/or or fracture of the prosthetic component and prosthetic fracture (6-30%). Conclusion: All-on-Four® is a procedure that has a high survival rate.